The 12 closest competitors and alternatives to LITTLE GREEN PHARMA LTD among pharmaceuticals, biotechnology & life sciences companies — ranked by similarity to what LITTLE GREEN PHARMA LTD actually does, not by market-cap band.
Subscribe to see LITTLE GREEN PHARMA LTD’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Little Green Pharma Ltd, established in 2016 and based in West Perth, Australia, specializes in the worldwide cultivation, manufacturing, and distribution of medicinal cannabis products. Its extensive product range encompasses cannabis flower medicines, various cannabis extracts, tinctures, and active pharmaceutical ingredients (APIs), serving markets both within Australia and internationally.
LITTLE GREEN PHARMA LTD is a pharmaceuticals, biotechnology & life sciences company headquartered in Wembley, Australia. It is publicly listed (LGP) with a market capitalisation of $15.6M. Xcout tracks 17 named people at LITTLE GREEN PHARMA LTD, including Jason Rance (Chief Executive Officer (Australia)).
11 more named people on record for LITTLE GREEN PHARMA LTD, with roles, board committees and tenure — see the full roster →
Ranked by semantic similarity — how close each company is to LITTLE GREEN PHARMA LTD by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Pharmaceuticals
MediPharm Labs Corp. operates as a pharmaceutical entity, specializing in the creation and global commercialization of premium, pharmaceutical-grade cannabis oils, concentrates, and sophisticated derivative products. Its market reach extends across Canada, Australia, Germany, and other international territories. The company manages the full cycle from developing and processing to packaging and distributing a diverse array of cannabis extracts and advanced cannabinoid-based formulations. Furthermore, MediPharm Labs provides auxiliary services including GMP-certified flower procurement, specialized packaging, and comprehensive logistics. This enterprise was established in 2015 and has its corporate headquarters situated in Barrie, Canada.
Pharmaceuticals
Hellenic Dynamics Plc, founded in 2018 and headquartered in London, United Kingdom, focuses on cultivating and distributing high-THC medical cannabis flowers across Europe.
Pharmaceuticals
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.
Pharmaceuticals
GL Pharma is an Austrian pharmaceutical company that develops, produces, and distributes branded products and generics for the treatment of serious and chronic diseases.
Similar pharmaceuticals, biotechnology & life sciences company
Mayne Pharma Group Ltd. operates as a specialized pharmaceutical enterprise, dedicated to the global production and distribution of both proprietary (branded) and unbranded (generic) medicinal products. Its extensive market reach spans Australia, New Zealand, North America (the United States and Canada), Europe, and Asia. The company's business activities are organized across four distinct divisions: Metrics Contract Services, International, Branded Products, and Portfolio Products. Mayne Pharma offers innovative oral drug delivery technologies and provides comprehensive contract services, including pharmaceutical development, manufacturing, and analytical support to external clients. Furthermore, the firm specializes in the distribution of pharmaceutical products tailored for key therapeutic areas such as dermatology, women's health, and infectious diseases. Incorporated in 2005, and headquartered in Salisbury South, Australia, the company was formerly known as Halcygen Pharmaceuticals Limited before rebranding to Mayne Pharma Group Limited in November 2010.
Pharmaceuticals
PharmaCielo Ltd., operating in conjunction with its subsidiary, is primarily engaged in the comprehensive cultivation, processing, and distribution of pharmaceutical-grade cannabis extracts, including tetrahydrocannabinol (THC), and associated medicinal products. Additionally, the company diversifies its offerings by providing telemedicine software. Its clientele spans a range of entities, such as health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies, across both Canada and Colombia. PharmaCielo also holds a strategic partnership with AssuredTrans Inc., and its corporate headquarters are situated in Toronto, Canada.
Pharmaceuticals
IM Cannabis Corp. specializes in the cultivation, production, and provision of medicinal cannabis goods throughout international markets such as Israel, Germany, and Canada. The company offers a range of cannabis products, including flowers and specifically formulated cannabis extracts, marketed under its IMC brand. Furthermore, it supplies dried flower, pre-rolled products, and compressed hashish via its WAGNERS and Highland Grow labels. IM Cannabis Corp. serves a broad customer base, addressing the needs of both medical patients and adult recreational consumers. Its corporate headquarters are located in Tel Aviv-Yafo, Israel.
Pharmaceuticals
SK-Pharma is a global pharmaceutical company and supplier of medications, specializing in early generics, rare drugs, value-added generics, and specialty products such as orphan drugs and complex generics. The company focuses on improving drug accessibility, market monitoring, and supply chain optimization to serve patients worldwide.
Biotechnology & Pharmaceuticals
Vesalius Longevity Labs operates a B2Doctor platform that provides peptide therapeutics and related products exclusively to licensed healthcare providers and clinical networks. The company manufactures and distributes peptides across multiple delivery formats—including subcutaneous, transdermal, intranasal, oral, and topical—utilizing cGMP-aligned manufacturing and third-party verification.
Pharmaceuticals
China Traditional Chinese Medicine Holdings Co. Limited functions as an investment holding company, primarily focusing on the research, development, and sale of traditional Chinese medicine and other pharmaceutical goods across the People's Republic of China. The company's product range includes medicinal granules, finished pharmaceutical preparations, pre-portioned decoction materials, and various healthcare products. Furthermore, its operations extend to the cultivation and management of Chinese medicinal herbs, the manufacturing of traditional Chinese medicines, and the trading of pharmaceutical products. It also delivers marketing, advertising, and consulting services related to TCM, and operates retail outlets for pharmaceuticals and decoction products. Property leasing services represent another facet of its business. The company distributes its products to healthcare facilities and retail pharmacies. Established in 1573 and headquartered in Wan Chai, Hong Kong, the firm was formerly known as China Traditional Chinese Medicine Co. Limited before adopting its current name in July 2016.
Pharmaceuticals
Pharmesis International Ltd. specializes in the research, development, production, and sales of Western medicine and Traditional Chinese Medicine products. The company manufactures pharmaceutical brands such as Kinna and Longlife, distributing them primarily to hospitals across the People's Republic of China.
Pharmaceuticals
Golden Throat Holdings Group Company Limited operates as an investment holding entity primarily engaged in the production and distribution of pharmaceutical goods, health-focused foods, and various other products within the People's Republic of China. Among its offerings are the widely recognized Golden Throat lozenges, an over-the-counter remedy designed to alleviate discomfort from sore and dry throats, as well as hoarseness often stemming from acute pharyngitis. The company further expands its Golden Throat lozenge line with products like Dule lozenges and their sugar-free counterparts, available in diverse flavors including orange, fructus momordicae, chrysanthemum, American ginseng, and hawthorn. Additionally, Golden Throat manufactures the Yinxingye tablet, formulated to enhance blood circulation, disperse blood stasis, and clear energy pathways. Its product portfolio also encompasses herbal vegetable beverages, crafted to provide vocal comfort and soothe irritated throats. Beyond its domestic market, the company extends its reach globally, exporting its range of products to countries and regions such as the United States, Canada, Russia, the European Union, Australia, Southeast Asia, the Middle East, Mexico, and across Africa. Established in 1956, Golden Throat Holdings Group Company Limited maintains its corporate headquarters in Liuzhou, within the People's Republic of China.
Search any company we track to see its competitive set.
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
Funding, investors, tech stack, hiring signals, leadership and corporate events — for LITTLE GREEN PHARMA LTDand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →